Prof. Lidia Karabon received her Master's Degree from Wroclaw University of Science and Technology, Chemical Faculty; PhD Degree from Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences; and Habilitation from Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences. She was employed at Wroclaw University of Science and Technology, Faculty of Chemistry, Lower Silesian Center of Tuberculosis and Lung Diseases, and she was part of the Bone Marrow Transplantation Team. In 2002–2005, she was the head of the HLA Laboratory, Dolnośląskie Center of Cell Transplantation. In 2006, she joined the Ludwik Hirszfeld Institute of Immunology and Experimental Therapy. She is a member of the European Federation for Immunogenetics, the Polish Association for Immunogenetics (President 2014-2022), and the Polish Association of Experimental and Clinical Immunology. Her scientific interests include the genetics and epigenetics of human diseases, especially the genetics and epigenetics of immune checkpoint receptors. Currently, she is the head of a task aimed at optimizing the process of lymphocyte transduction to produce CAR-T cells in a project carried out by the Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, funded by the Medical Research Agency.